Subscribe
ericsphotography-istockphoto-com-us-gavel-2-1
ericsphotography / iStockphoto.com
14 November 2017Americas

Federal Circuit reverses its earlier ruling in Life Technologies v Promega

The US Court of Appeals for the Federal Circuit has reversed its findings in Life Technologies v Promega, nine months after the US Supreme Court limited overseas patent infringement.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
SCOTUS reverses Federal Circuit in Life Technologies v Promega
22 February 2017   The US Supreme Court today ruled that supplying a single component of a multi-component invention for manufacture abroad does not constitute patent infringement.
Americas
Life v Promega reaction: SCOTUS raises more questions
23 February 2017   The US Supreme Court has “left more questions than it answered” in the Life Technologies v Promega ruling, which was handed down yesterday, according to lawyers.


Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024

Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024

More on this story

Americas
SCOTUS reverses Federal Circuit in Life Technologies v Promega
22 February 2017   The US Supreme Court today ruled that supplying a single component of a multi-component invention for manufacture abroad does not constitute patent infringement.
Americas
Life v Promega reaction: SCOTUS raises more questions
23 February 2017   The US Supreme Court has “left more questions than it answered” in the Life Technologies v Promega ruling, which was handed down yesterday, according to lawyers.

More on this story

Americas
SCOTUS reverses Federal Circuit in Life Technologies v Promega
22 February 2017   The US Supreme Court today ruled that supplying a single component of a multi-component invention for manufacture abroad does not constitute patent infringement.
Americas
Life v Promega reaction: SCOTUS raises more questions
23 February 2017   The US Supreme Court has “left more questions than it answered” in the Life Technologies v Promega ruling, which was handed down yesterday, according to lawyers.

More features

Gilead awarded $30m over counterfeit HIV drug scheme
EPO invalidates human milk patent after Nestle opposition
Bayer gains exclusive licence for heart drug in Japan
EPO delivers key Novo Nordisk, GSK and Inhibrx rulings
McGuireWoods expands team with ex-Novo Nordisk GC
Paul, Weiss swoops for senior duo from Weil, Gotshal
UPC bans Meril Life Sciences from selling infringing heart valve
SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic